after Iceland’s health regulator flagged three cases of patients thinking about suicide or self-harm.An EMA safety committee is looking into adverse events raised by the Icelandic Medicines Agency, including two cases of suicidal thoughts in those who used Ozempic, which contains the active ingredient semaglutide, and Saxenda, the regulator said.
Novo Nordisk said patient safety was top priority and it treated all reports about adverse events very seriously.Ozempic: How a Canadian scientist and a venomous lizard paved way for popular diabetes drug
Health Health Latest News, Health Health Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Source: GlobalNational - 🏆 81. / 51 Read more »